Search research articles
Contact Us
Filters
Showing results (131-140 of 165) with videos related to
Page
of 17
Sort By:
Clinical and Experimental Immunology
|
October 2, 2008
Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypes
D Santini, S Angeletti, A Ruzzo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 1, 2010
Early magnesium modifications as a surrogate marker of efficacy of cetuximab-based anticancer treatment in KRAS wild-type advanced colorectal cancer patients
B Vincenzi, S Galluzzo, D Santini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 27, 2005
Interleukin 1B gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms in Helicobacter pylori-negative gastric cancer of intestinal and diffuse histotype
A Ruzzo, F Graziano, F Pizzagalli, et al.
British Journal of Cancer
|
April 15, 2004
High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)
S Cascinu, M Scartozzi, R Labianca, et al.
Cancer Immunology Research
|
January 12, 2017
Temporally Distinct PD-L1 Expression by Tumor and Host Cells Contributes to Immune Escape
Takuro Noguchi, Jeffrey P Ward, Matthew M Gubin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 20, 2011
An EZH2 polymorphism is associated with clinical outcome in metastatic colorectal cancer patients
F Crea, L Fornaro, E Paolicchi, et al.
Human Mutation
|
January 16, 2007
Identification of seven novel germline mutations in the human E-cadherin (CDH1) gene
H More, B Humar, W Weber, et al.
Blood Advances
|
January 4, 2018
PD-1 blockade enhances elotuzumab efficacy in mouse tumor models
Natalie A Bezman, Amy Jhatakia, Alper Y Kearney, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam
|
February 7, 2019
Natural Killer Response and Lipo-Metabolic Profile in Adults with Low HDL-Cholesterol and Mild Hypercholesterolemia: Beneficial Effects of Artichoke Leaf Extract Supplementation
M Rondanelli, A M Castellazzi, A Riva, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 9, 2000
Triggering Fc alpha-receptor I (CD89) recruits neutrophils as effector cells for CD20-directed antibody therapy
B Stockmeyer, M Dechant, M van Egmond, et al.
Page
of 17
Search research articles
Search
Showing results (131-140 of 165) with videos related to
Sort By:
Page
of 17
Clinical and Experimental Immunology
|
October 2, 2008
Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypes
D Santini, S Angeletti, A Ruzzo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 1, 2010
Early magnesium modifications as a surrogate marker of efficacy of cetuximab-based anticancer treatment in KRAS wild-type advanced colorectal cancer patients
B Vincenzi, S Galluzzo, D Santini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 27, 2005
Interleukin 1B gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms in Helicobacter pylori-negative gastric cancer of intestinal and diffuse histotype
A Ruzzo, F Graziano, F Pizzagalli, et al.
British Journal of Cancer
|
April 15, 2004
High curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)
S Cascinu, M Scartozzi, R Labianca, et al.
Cancer Immunology Research
|
January 12, 2017
Temporally Distinct PD-L1 Expression by Tumor and Host Cells Contributes to Immune Escape
Takuro Noguchi, Jeffrey P Ward, Matthew M Gubin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 20, 2011
An EZH2 polymorphism is associated with clinical outcome in metastatic colorectal cancer patients
F Crea, L Fornaro, E Paolicchi, et al.
Human Mutation
|
January 16, 2007
Identification of seven novel germline mutations in the human E-cadherin (CDH1) gene
H More, B Humar, W Weber, et al.
Blood Advances
|
January 4, 2018
PD-1 blockade enhances elotuzumab efficacy in mouse tumor models
Natalie A Bezman, Amy Jhatakia, Alper Y Kearney, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam
|
February 7, 2019
Natural Killer Response and Lipo-Metabolic Profile in Adults with Low HDL-Cholesterol and Mild Hypercholesterolemia: Beneficial Effects of Artichoke Leaf Extract Supplementation
M Rondanelli, A M Castellazzi, A Riva, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 9, 2000
Triggering Fc alpha-receptor I (CD89) recruits neutrophils as effector cells for CD20-directed antibody therapy
B Stockmeyer, M Dechant, M van Egmond, et al.
Page
of 17